Skip to main content

Some Biotech Stocks Are Now Cheap

To start 2022, biotechnology stocks aren’t convincing investors that the group is ready to snap out of a funk that extends back to last year. Investors looking for good news among biotechnology equities can lean on valuation, and while valuation alone isn’t a reason to buy or sell a...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.